Cargando…
Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
Continuous drug delivery (CDD) is used in moderately advanced and late-stage Parkinson’s disease (PD) to control motor and non-motor fluctuations (‘OFF’ periods). Transdermal rotigotine is indicated for early fluctuations, while subcutaneous apomorphine infusion and levodopa-carbidopa intestinal gel...
Autores principales: | Rota, Silvia, Urso, Daniele, van Wamelen, Daniel J., Leta, Valentina, Boura, Iro, Odin, Per, Espay, Alberto J., Jenner, Peter, Chaudhuri, K. Ray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558383/ https://www.ncbi.nlm.nih.gov/pubmed/36229860 http://dx.doi.org/10.1186/s40035-022-00317-x |
Ejemplares similares
-
Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease
por: van Wamelen, Daniel J., et al.
Publicado: (2018) -
Viruses, parkinsonism and Parkinson’s disease: the past, present and future
por: Leta, Valentina, et al.
Publicado: (2022) -
Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism
por: Leta, Valentina, et al.
Publicado: (2022) -
Rotigotine Transdermal Patch for Motor and Non-motor Parkinson’s Disease: A Review of 12 Years’ Clinical Experience
por: Raeder, Vanessa, et al.
Publicado: (2021) -
Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease
por: Urso, Daniele, et al.
Publicado: (2021)